Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00983528
Brief Title: Alemtuzumab and Clofarabine for Relapsed or Refractory Acute Lymphoblastic Leukemia

First Submitted : September 23, 2009
First Submitted that Met QC Criteria : September 23, 2009
First Posted : September 24, 2009 (Estimate)

Results First Submitted : January 23, 2020
Results First Submitted that Met QC Criteria : July 29, 2020
Results First Posted : August 12, 2020

Last Update Submitted that Met QC Criteria : July 29, 2020
Last Update Posted : August 12, 2020